19 research outputs found

    Two ZNF509 (ZBTB49) isoforms induce cell-cycle arrest by activating transcription of p21/CDKN1A and RB upon exposure to genotoxic stress

    Get PDF
    ZNF509 is unique among POK family proteins in that four isoforms are generated by alternative splicing. Short ZNF509 (ZNF509S1, -S2 and -S3) isoforms contain one or two out of the seven zinc-fingers contained in long ZNF509 (ZNF509L). Here, we investigated the functions of ZNF509 isoforms in response to DNA damage, showing isoforms to be induced by p53. Intriguingly, to inhibit proliferation of HCT116 and HEK293 cells, we found that ZNF509L activates p21/CDKN1A transcription, while ZNF509S1 induces RB. ZNF509L binds to the p21/CDKN1A promoter either alone or by interacting with MIZ-1 to recruit the co-activator p300 to activate p21/CDKN1A transcription. In contrast, ZNF509S1 binds to the distal RB promoter to interact and interfere with the MIZF repressor, resulting in derepression and transcription of RB. Immunohistochemical analysis revealed that ZNF509 is highly expressed in normal epithelial cells, but was completely repressed in tumor tissues of the colon, lung and skin, indicating a possible role as a tumor suppressorope

    Kr-pok increases FASN expression by modulating the DNA binding of SREBP-1c and Sp1 at the proximal promoter

    Get PDF
    Kr-pok (kidney cancer-related POZ domain and Krรผppel-like protein) is a new proto-oncogenic POZ-domain transcription factor. Fatty acid synthase gene (FASN) encodes one of the key enzymes in fatty acids synthesis and is the only enzyme that synthesizes fatty acids in cancer cells. Sp1 and SREBP-1c are the two major transcription activators of FASN. We investigated whether Kr-pok modulates transcription of the FASN. FASN expression is significantly decreased in Kr-pok knockout murine embryonic fibroblasts. Coimmunoprecipitation, GST fusion protein pull-down, and immunocytochemistry assays show that the zinc-finger domain of Kr-pok interacts directly with the bZIP DNA binding domain of SREBP-1. Electrophoretic mobility shift assay, oligonucleotide pull-down, and chromatin immunoprecipitation assays showed that Kr-pok changes the transcription factor binding dynamics of Sp1 and SREBP-1c to the SRE/E-box elements of the proximal promoter. We found that Kr-pok expression increased during 3T3-L1 preadipocyte differentiation and that FASN expression is decreased by the knockdown of Kr-pok. Kr-pok facilitates the SREBP-1c-mediated preadipocyte differentiation and/or fatty acid synthesis. Kr-pok may act as an important regulator of fatty acid synthesis and may induce rapid cancer cell proliferation by increasing palmitate synthesis.ope

    KR-POK interacts with p53 and represses its ability to activate transcription of p21WAF1/CDKN1A.

    Get PDF
    Transcriptional regulation by p53 is thought to play a role in its ability to suppress tumorigenesis. However, there remain gaps in understanding about how p53 regulates transcription and how disrupting this function may promote cancer. Here we report a role in these processes for the kidney cancer-related gene KR-POK (ZBTB7C), a POZ domain and Krรผppel-like zinc finger transcription factor that we found to physically interact with p53. Murine embryonic fibroblasts isolated from genetically deficient mice (Kr-pok(-/-) MEFs) exhibited a proliferative defect relative to wild-type mouse embryonic fibroblasts (MEF). The zinc finger domain of Kr-pok interacted directly with the DNA binding and oligomerization domains of p53. This interaction was essential for Kr-pok to bind the distal promoter region of the CDKN1A gene, an important p53 target gene encoding the cell-cycle regulator p21WAF1, and to inhibit p53-mediated transcriptional activation of CDKN1A. Kr-pok also interacted with the transcriptional corepressors NCoR and BCoR, acting to repress histone H3 and H4 deacetylation at the proximal promoter region of the CDKN1A gene. Importantly, Kr-pok(-/-) MEFs displayed an enhancement in CDKN1A transactivation by p53 during the DNA damage response, without any parallel changes in transcription of either the p53 or Kr-pok genes themselves. Furthermore, Kr-pok promoted cell proliferation in vitro and in vivo, and its expression was increased in more than 50% of the malignant human kidney cancer cases analyzed. Together, our findings define KR-POK as a transcriptional repressor with a pro-oncogenic role that relies upon binding to p53 and inhibition of its transactivation function.ope

    The proto-oncoprotein FBI-1 interacts with MBD3 to recruit the Mi-2/NuRD-HDAC complex and BCoR and to silence p21WAF/CDKN1A by DNA methylation

    Get PDF
    The tumour-suppressor gene CDKN1A (encoding p21Waf/Cip1) is thought to be epigenetically repressed in cancer cells. FBI-1 (ZBTB7A) is a proto-oncogenic transcription factor repressing the alternative reading frame and p21WAF/CDKN1A genes of the p53 pathway. FBI-1 interacts directly with MBD3 (methyl-CpGโ€“binding domain protein 3) in the nucleus. We demonstrated that FBI-1 binds both non-methylated and methylated DNA and that MBD3 is recruited to the CDKN1A promoter through its interaction with FBI-1, where it enhances transcriptional repression by FBI-1. FBI-1 also interacts with the co-repressors nuclear receptor corepressor (NCoR), silencing mediator for retinoid and thyroid receptors (SMRT) and BCL-6 corepressor (BCoR) to repress transcription. MBD3 regulates a molecular interaction between the co-repressor and FBI-1. MBD3 decreases the interaction between FBI-1 and NCoR/SMRT but increases the interaction between FBI-1 and BCoR. Because MBD3 is a subunit of the Mi-2 autoantigen (Mi-2)/nucleosome remodelling and histone deacetylase (NuRD)-HDAC complex, FBI-1 recruits the Mi-2/NuRD-HDAC complex via MBD3. BCoR interacts with the Mi-2/NuRD-HDAC complex, DNMTs and HP1. MBD3 and BCoR play a significant role in the recruitment of the Mi-2/NuRD-HDAC complexโ€“ and the NuRD complexโ€“associated proteins, DNMTs and HP. By recruiting DNMTs and HP1, Mi-2/NuRD-HDAC complex appears to play key roles in epigenetic repression of CDKN1A by DNA methylation.ope

    ZBTB2 increases PDK4 expression by transcriptional repression of RelA/p65

    Get PDF
    The NF-ฮบB is found in almost all animal cell types and is involved in a myriad of cellular responses. Aberrant expression of NF-ฮบB has been linked to cancer, inflammatory diseases and improper development. Little is known about transcriptional regulation of the NF-ฮบB family member gene RelA/p65. Sp1 plays a key role in the expression of the RelA/p65 gene. ZBTB2 represses transcription of the gene by inhibiting Sp1 binding to a Sp1-binding GC-box in the RelA/p65 proximal promoter (bp, -31 to -21). Moreover, recent studies revealed that RelA/p65 directly binds to the peroxisome proliferator-activated receptor-ฮณ coactivator1ฮฑ (PGC1ฮฑ) to decrease transcriptional activation of the PGC1ฮฑ target gene PDK4, whose gene product inhibits pyruvate dehydrogenase (PDH), a key regulator of TCA cycle flux. Accordingly, we observed that RelA/p65 repression by ZBTB2 indirectly results in increased PDK4 expression, which inhibits PDH. Consequently, in cells with ectopic ZBTB2, the concentrations of pyruvate and lactate were higher than those in normal cells, indicating changes in glucose metabolism flux favoring glycolysis over the TCA cycle. Knockdown of ZBTB2 in mouse xenografts decreased tumor growth. ZBTB2 may increase cell proliferation by reprogramming glucose metabolic pathways to favor glycolysis by upregulating PDK4 expression via repression of RelA/p65 expression.ope

    ํ™•์žฅ๋œ ๊ณ„ํšํ–‰๋™์ด๋ก ์„ ํ†ตํ•œ ๊ตญ๋ฏผ์ฒด๋ ฅ 100 ์ฐธ์—ฌ์ž์˜ ์žฌ์ฐธ์—ฌ ์˜๋„์— ๊ด€ํ•œ ์—ฐ๊ตฌ

    Get PDF
    ํ•™์œ„๋…ผ๋ฌธ (์„์‚ฌ) -- ์„œ์šธ๋Œ€ํ•™๊ต ๋Œ€ํ•™์› : ์‚ฌ๋ฒ”๋Œ€ํ•™ ์ฒด์œก๊ต์œก๊ณผ,๊ธ€๋กœ๋ฒŒ์Šคํฌ์ธ ๋งค๋‹ˆ์ง€๋จผํŠธ์ „๊ณต, 2020. 8. Lee, Chung Gun.The average life expectancy of Koreans is increasing due to the development of medical science, improvements in life quality, and a general interest in health (KOSIS, 2018). However, although life expectancy has increased, the concept of health-adjusted life expectation (HALE) should also be considered. This is an indicator that estimates the average years a person can expect to live healthily. Some researchers think that HALE represents the best measurement for estimating the overall level of health for citizens. Consequently, the WHO (World Health Organization) use the concept as an official judgement criterion for yearly reports to provide information about the average level of healthy life for membership states (Lee et al., 2016). To live healthily and maintain quality of life, it is essential for people to manage physical fitness and participate in exercise. The effects of exercise have been proven by many research studies and the effects of exercise are apparent at all ages. The Korean government and the Ministry of Culture, Sports, and Tourism started the National Fitness Award (NFA; so-called Public Health 100 in Korea) program to promote sports and extend HALE by providing scientific measurement, exercise prescription, and eight weeks of exercise classes. After measurement, the Korea Sports Promotion Foundation (KSPO) give awards depending on the results. As well as Korea, other developed countries have designed sport programs based on life cycle and ages (Kim, 2014). The KSPO has operated the program since 2011, when an initial pilot program began with 4 centers and approximately 4,500 participants. Up to 2018, the KSPO and local government expanded the number of branches from 4 to 43, and the number of participants has increased to 267,729. The KSPO aims to add 8 more centers and increase the number of participants to approximately 300,000 (KSPO, 2019). However, according to the KSPO, only 0.56% of the population participated this program and one third of people who took part revisited the measurement. The NFA needs to expand further to promote healthy living and provide motivation to encourage participation in sport. The Korean government already spends a significant proportion of the budget (more than 10.7 billion won) on this program, which represents sports-related policy and the KSPO. This study was designed to identify factors that affect peoples intention to visit the scheme by applying the theory of planned behavior (TPB). This is one of the most well-known theories related to human behavior, and is used to predict exercise behavior, as well as for persuasive communication research, to structuralize attitudes, subjective norms, perceived control, intention, and behavior (Cho, 2012; Kim, Lee & Kim, 2003). However, some researchers indicate that the three components of TPB lack descriptive power for predicting human behavior (Armitage & Conner, 2001; Rivis & Sheeran, 2003). The need for new explanatory variables to mitigate the limitations of TPB led to the advanced and extended theory of planned behavior to include additional variables (Hagger et al., 2002; Kim, 2017). In this study, the concepts of spatial and temporal distance - aspects of the construal level theory (CLT) that affect intention and attitudes - are used as additional variables to extend TPB so that decision making in relation to revisiting the NFA scheme can be examined.๋ณธ ์—ฐ๊ตฌ์˜ ๋ชฉ์ ์€ ํ™•์žฅ๋œ ๊ณ„ํšํ–‰๋™์ด๋ก (Extended Theory of Planned Behavior)์„ ํ™œ์šฉํ•˜์—ฌ ๊ตญ๋ฏผ์ฒด๋ ฅ100(National Fitness Award) ์ฐธ์—ฌ์ž๋“ค์˜ ์žฌ์ฐธ์—ฌ ์˜๋„๋ฅผ ์‚ดํŽด๋ณด๋Š”๋ฐ ์žˆ๋‹ค. ๊ณ„ํš๋œ ํ–‰๋™์ด๋ก (Theory of Planned Behavior)์˜ ํƒœ๋„, ์‚ฌํšŒ์ ๊ทœ๋ฒ”, ์ธ์ง€๋œ ํ–‰๋™ํ†ต์ œ์™€ ํ•ด์„์ˆ˜์ค€์ด๋ก (Construal Level Theory)์˜ ์‹œ๊ฐ„์ , ๊ณต๊ฐ„์  ๊ฑฐ๋ฆฌ๊ฐ€ ์žฌ์ฐธ์—ฌ์— ๋Œ€ํ•œ ํƒœ๋„ ๋ฐ ์˜๋„์— ๋ฏธ์น˜๋Š” ์˜ํ–ฅ์„ ๊ทœ๋ช…ํ•˜์˜€๋‹ค. ํ•ด์„์ˆ˜์ค€์ด๋ก ์˜ ์‹œ๊ฐ„์  ๊ฑฐ๋ฆฌ๋Š” ๋ฏธ๋ž˜์˜ ์ƒํ™ฉ์ด ํ˜„์žฌ๋กœ๋ถ€ํ„ฐ ์‹œ๊ฐ„์ ์œผ๋กœ ์–ผ๋งˆ๋‚˜ ๋–จ์–ด์ ธ ์žˆ๋Š”์ง€์— ๋Œ€ํ•œ ์ฃผ๊ด€์  ์ธ์‹์ด๊ณ , ๊ณต๊ฐ„์  ๊ฑฐ๋ฆฌ๋Š” ๋ฏธ๋ž˜์˜ ์ƒํ™ฉ์ด ๋‚˜๋กœ๋ถ€ํ„ฐ ๊ณต๊ฐ„์ ์œผ๋กœ ์–ผ๋งˆ๋‚˜ ๋ฉ€๋ฆฌ ๋–จ์–ด์ ธ ์žˆ๋Š”์ง€์— ๋Œ€ํ•œ ์ฃผ๊ด€์  ์ธ์‹์ด๋‹ค. ์˜ฌ๋ฆผํ”ฝ๊ณต์›์— ์œ„์น˜ํ•œ ๊ตญ๋ฏผ์ฒด๋ ฅ์„ผํ„ฐ๋ฅผ ๋ฐฉ๋ฌธํ•˜๋Š” ๋ฐฉ๋ฌธ๊ฐ์„ ๋Œ€์ƒ์œผ๋กœ ์„ค๋ฌธ์„ ์‹ค์‹œํ•˜์˜€์œผ๋ฉฐ, ์ˆ˜์ง‘๋œ ์ด 226๋ถ€์˜ ์„ค๋ฌธ์ง€๋ฅผ SPSS 22์™€ AMOS 22๋ฅผ ํ†ตํ•ด ํ™•์ธ์  ์š”์ธ๋ถ„์„ ๋ฐ ๊ตฌ์กฐ๋ฐฉ์ •์‹ ๋ชจํ˜•์„ ํ†ตํ•ด ๋ถ„์„์„ ์‹ค์‹œํ•˜์˜€๋‹ค. ์—ฐ๊ตฌ๊ฒฐ๊ณผ ๊ณ„ํš๋œ ํ–‰๋™์ด๋ก ์˜ ๊ตฌ์„ฑ์š”์†Œ ์ค‘ ํƒœ๋„, ์ธ์ง€๋œ ํ–‰๋™ํ†ต์ œ๋Š” ์žฌ์ฐธ์—ฌ ์˜๋„์— ์ •(+)์˜ ์˜ํ–ฅ์„ ๋ฏธ์น˜๋Š” ๊ฒƒ์œผ๋กœ ๋‚˜ํƒ€๋‚ฌ๋‹ค. ํ•˜์ง€๋งŒ ์‚ฌํšŒ์  ๊ทœ๋ฒ”์€ ์žฌ๋ฐฉ๋ฌธ ์˜๋„์— ์˜ํ–ฅ์„ ๋ฏธ์น˜์ง€ ์•Š๋Š” ๊ฒƒ์œผ๋กœ ๋‚˜ํƒ€๋‚ฌ๋‹ค. ์‹œ๊ฐ„์  ๊ฑฐ๋ฆฌ์˜ ๊ฒฝ์šฐ, ์žฌ์ฐธ์—ฌ์— ๋Œ€ํ•œ ํƒœ๋„์™€ ์˜๋„์— ์ •(+)์˜ ์˜ํ–ฅ์„ ๋ฏธ์น˜๋Š” ๊ฒƒ์œผ๋กœ ๋‚˜ํƒ€๋‚ฌ๋‹ค. ์ฆ‰ ์‹œ๊ฐ„์ ์œผ๋กœ ์žฌ์ธก์ •๊นŒ์ง€ ๋งŽ์ด ๋‚จ์•„์žˆ๋‹ค๊ณ  ๋Š๋‚„์ˆ˜๋ก ๊ฐ€์น˜ ์ค‘์‹ฌ์ ์ธ ์ƒ์œ„ํ•ด์„์ˆ˜์ค€์ด ์ž‘์šฉํ•˜์—ฌ ์žฌ์ฐธ์—ฌ์— ๋Œ€ํ•œ ํƒœ๋„์™€ ๋ฐฉ๋ฌธ์˜๋„๊ฐ€ ์ฆ๊ฐ€ํ•œ๋‹ค. ํ•œํŽธ, ๊ณต๊ฐ„์  ๊ฑฐ๋ฆฌ์˜ ๊ฒฝ์šฐ ์žฌ์ฐธ์—ฌ์— ๋Œ€ํ•œ ํƒœ๋„ ๋ฐ ์˜๋„์™€ ๋ถ€์ (-) ์ƒ๊ด€๊ด€๊ณ„๊ฐ€ ์žˆ๋Š” ๊ฒƒ์œผ๋กœ ๋‚˜ํƒ€๋‚ฌ๋‹ค. ์ฐธ์—ฌ์ž๋“ค์ด ๊ตญ๋ฏผ์ฒด๋ ฅ์„ผํ„ฐ๊ฐ€ ๊ฐ€๊น๋‹ค๊ณ  ๋Š๋‚„์ˆ˜๋ก ๊ตฌ์ฒด์„ฑ๊ณผ ์‹คํ–‰๊ฐ€๋Šฅ์„ฑ ์ค‘์‹ฌ์˜ ํ•˜์œ„ํ•ด์„์ˆ˜์ค€์ด ์ž‘์šฉํ•˜์—ฌ ์žฌ์ฐธ์—ฌ์— ๋Œ€ํ•œ ํƒœ๋„์™€ ์˜๋„๊ฐ€ ์ฆ๊ฐ€ํ•˜๋Š” ๊ฒƒ์ด๋‹ค. ์ด์ฒ˜๋Ÿผ ์ฐธ์—ฌ์ž๊ฐ€ ์ง€๊ฐํ•˜๋Š” ์‹ฌ๋ฆฌ์  ๊ฑฐ๋ฆฌ๊ฐ์— ๋”ฐ๋ผ ๊ฐ๊ธฐ ๋‹ค๋ฅธ ํ•ด์„์ˆ˜์ค€์ด ์ž‘์šฉํ•˜๊ฒŒ ๋˜๊ณ , ํ•ด์„์ˆ˜์ค€์„ ํ† ๋Œ€๋กœ ์ปค๋ฎค๋‹ˆ์ผ€์ด์…˜ ๋ฉ”์„ธ์ง€๋ฅผ ์ „๋‹ฌํ•˜๋ฉด ์„ค๋“๋ ฅ์„ ๋†’์ผ ์ˆ˜ ์žˆ๋‹ค. ๋”ฐ๋ผ์„œ ๋ณธ ์—ฐ๊ตฌ๊ฒฐ๊ณผ๋Š” ๊ตญ๋ฏผ์ฒด๋ ฅ100 ์ฐธ๊ฐ€์ž๋“ค์˜ ์žฌ์ฐธ์—ฌ ์˜์‚ฌ๊ฒฐ์ •์„ ์œ ๋„ํ•˜๊ณ  ํ”„๋กœ๊ทธ๋žจ ํ™œ์„ฑํ™”๋ฅผ ์œ„ํ•œ ๋งˆ์ผ€ํŒ… ์ „๋žต์„ ์ˆ˜๋ฆฝํ•˜๋Š”๋ฐ ๋„์›€์„ ์ค„ ๊ฒƒ์œผ๋กœ ๊ธฐ๋Œ€ํ•œ๋‹ค.Chapter 1. Introduction 1 1.1. Background and Necessity of the Research 1 1.2. Purpose of Research 7 1.3. Research hypothesis 7 Chapter 2. Theoretical Background 10 2.1. The Theory of Reasoned Action 11 2.2. The Theory of Planned Behavior 15 2.3. The extended Theory of Planned Behavior 19 2.4. Construal Level Theory and Psychological Distance 21 2.4.1. Temporal Distance 23 2.4.2. Spatial Distance 24 2.5. National Fitness Award Program Overview 25 2.5.1. Necessity and Effect of National Fitness Award 27 2.5.2. National Fitness Award Management System 29 2.5.3. National Fitness Award Program Measurement Grade 30 Chapter 3. Methodology 35 3.1. Sampling 35 3.2. Survey Instrument 38 3.3. Procedure 41 3.4. Statistical analysis 41 3.4.1. Reliability and discriminant validity analysis 41 3.4.2. Confirmatory factor analysis 42 3.4.3. Structure Equation Model 43 Chapter 4. Results 44 4.1. Descriptive analysis 44 4.2. Reliability and discriminant validity analysis 46 4.3. Confirmatory factor analysis 47 4.4. Hypothesis testing 48 Chapter 5. Discussion 52 5.1. Summary of key findings 52 5.2. Theoretical and practical implication 54 5.3. Limitations and future research directions 56 Bibliography 58 Appendix A 72 Appendix B 76 ๊ตญ๋ฌธ์ดˆ๋ก 80Maste

    ์‹คํ—˜์  ํ์†์ƒ์—์„œ ์œ ๋ฐœ๊ฐ€๋Šฅ ์‚ฐํ™”์งˆ์†Œ์ƒ์‚ฐํšจ์†Œ(iNOS)์˜ ์—ญํ• 

    No full text
    Thesis(doctor`s)--์„œ์šธ๋Œ€ํ•™๊ต ๋Œ€ํ•™์› :์˜ํ•™๊ณผ ๋ณ‘๋ฆฌํ•™์ „๊ณต,2007.Docto

    ePRO-MP๋ฅผ ์ด์šฉํ•œ ๋ฉ€ํ‹ฐํ”„๋กœ์„ธ์„œ ์†Œํ”„ํŠธ์›จ์–ด์˜ ์—๋„ˆ์ง€์™€ ์„ฑ๋Šฅ ์ตœ์ ํ™”

    No full text
    Thesis(masters) --์„œ์šธ๋Œ€ํ•™๊ต ๋Œ€ํ•™์› :์ „๊ธฐ. ์ปดํ“จํ„ฐ๊ณตํ•™๋ถ€, 2009.2.Maste

    ๋ฐœ์•” ๋‹จ๋ฐฑ์งˆ PLZF์™€ PLZF-RARฮฑ์˜ ๋ถ„์ž์ˆ˜์ค€์—์„œ์˜ ๊ธฐ๋Šฅ ๋™์ • ๋ฐ ์ž‘์šฉ์  ๊ทœ๋ช…

    No full text
    Dept. of Medical Science/๋ฐ•์‚ฌAberrant transcription repression through chromatin remodeling and histone deacetylation has been postulated as the driving force for tumorigenesis. PLZF (promyelocytic leukemia zinc finger) is initially isolated in fusion protein form with RARฮฑ (retinoic acid receptor alpha), which causes in APL (acute promyelocytic leukemia)-type leukemia. IHC(immunohistochemistry) of tumor microtissues arrays and oncomine data indicate that PLZF is aberrantly overexpressed in some human solid tumors, such as kidney renal carcinoma, testis seminoma, brain glioblastoma, and prostate adenocarcinoma. The data suggest that PLZF may be an oncoprotein involved in oncogenesis and cell proliferation. PLZF-RARฮฑ is considered as oncoprotein generated by chromosomal translocation between PLZF andRARฮฑ genes in the APL-type leukemic patients. Although PLZF-RARฮฑ was shown to cause leukemia and the molecular interaction between PLZF-RARฮฑ and corepressor-HDAC (Histon deacetylase) complex is important in oncogenesis, the target genes and action mechanism of PLZF-RARฮฑ remained largely unknown.I found that PLZF can repress transcription of the p21WAF/CDKN1A gene encoding p21, by binding to the proximal Sp1-binding GC-box 5/6 and the distal p53-responsive elements of the CDKN1A promoter. PLZF can also repress transcription of TP53 and destabilize p53 by deacetylation and ubiquitination, which also decreases transcription of CDKN1A. PLZF interacts with co-repressors, such as mSin3A, NCoR and SMRT, and deacetylateshistones H3 and H4 of the nucleosomes around the p21WAF/CDKN1A promoter. PLZF is an oncoprotein that causes cellular transformation and promotes cell proliferation in the HEK293A, HCT116, and H460 cells. PLZF does not induce apoptosis. PLZF-RARฮฑ promotes cell proliferation by repressing the transcription of the CDKN1A gene. Molecular characterization of oncoprotein PLZF-RARฮฑ revealed molecular mechanism similar to thePLZF, but PLZF-RARฮฑ also showed unique features in transcriptional repression PLZF-RARฮฑ is a competitive transcription repressor of p53, RARฮฑ and Sp1 and was shown to bind the proximal Sp1-binding GC-boxes 3, 4, 5/6, the RARE and the distal p53-responsive elements of CDKN1A promoter. PLZF-RARฮฑ also interacted with co-repressors, such as mSin3A, NCoR and SMRT, thereby deacetylates histones H3 and H4 of the nucleosomes around the CDKN1A promoter. Additionally, I found that PLZFRARฮฑ interacts with MBD3-NuRD complex, which leads to epigenetic silencing of the CDKN1A by DNA methylation and heterochromatinformation. PLZF and PLZF-RARฮฑ are the oncoproteins that repress transcription of the CDKN1A of the p53 pathway, by direct binding competition to the key regulatory elements such as proximal GC-boxes, distal p53 binding elements and RARE with Sp1, p53, and RARฮฑ. PLZF and PLZFRARฮฑ also represses transcription of CDKN1A by repressing transcription ofTP53 and by controlling the stability of p53.prohibitio

    ์ƒˆ๋กœ์šด proto-oncogene์ธ FBI-1(pokemon/ZBTB7a)๋Š” cyclin-d

    No full text
    Dept. of Medical Science/์„์‚ฌ[ํ•œ๊ธ€]FBI-1 (Pokemon/ZBTB7a)๋Š” ์—ฌ๋Ÿฌ ์กฐ์ง์—์„œ ๋ฐœํ˜„๋˜๋Š” POK ๊ณ„์—ด์˜ ์ „ ๋ฐœ์•” ์œ ์ „์ž์ด๋‹ค. ์šฐ๋ฆฌ๋Š” FBI-1์˜ ์ƒ์ฒด ๋‚ด ๊ธฐ๋Šฅ์„ ์—ฐ๊ตฌํ•˜๋Š” ๊ณผ์ •์—์„œ, ์„ธํฌ ์ฃผ๊ธฐ ์กฐ์ ˆ์—์„œ ์ค‘์š”ํ•œ ์กฐ์ ˆ ๊ฒฝ๋กœ์ธ Arf-Mdm2-p53-p21 (p53 ๊ฒฝ๋กœ๋ผ ๋ถ€๋ฆ„) ์˜ ๋ชจ๋“  ์œ ์ „์ž๊ฐ€ FBI-1์— ์˜ํ•˜์—ฌ ๊ทธ ๋ฐœํ˜„์ด ์–ต์ œ๋˜๋Š” ํ‘œ์ ์ž„์„ ๋ฐœ๊ฒฌํ•˜์˜€๋‹ค. FBI-1์ด ์ˆ˜ํ–‰ํ•˜๋Š” ์„ธํฌ ์ฃผ๊ธฐ ์กฐ์ ˆ ๊ธฐ์ „์„ ์—ฐ๊ตฌํ•˜๊ณ ์ž, p53 ๊ฒฝ๋กœ์˜ Arf์™€ p53์˜ ํ•˜๋ถ€ ์œ ์ „์ž๋กœ์จ ์„ธํฌ ์ฃผ๊ธฐ ์กฐ์ ˆ์˜ ํ•ต์‹ฌ ์กด์ ˆ์ž์ธ p21Waf/Cip1์„ ์„ ํƒํ•˜์—ฌ ์—ฐ๊ตฌ๋ฅผ ์ง„ํ–‰ํ•˜์˜€๋‹ค. ์šฐ๋ฆฌ๋Š” FBI-1, p53, Sp1, FRE(FBI-1 ๊ฒฐํ•ฉ ๋ถ€์œ„)/Sp1-3 GC-box, ๊ทธ๋ฆฌ๊ณ  p53 ๊ฒฐํ•ฉ ๋ถ€์œ„๋ฅผ ํฌํ•จํ•˜๋Š” ๋ณต์žกํ•œ ๋ถ„์ž์  ๊ธฐ์ „์— ์˜ํ•˜์—ฌ p21 ์œ ์ „์ž์˜ ๋ฐœํ˜„์„ FBI-1์ด ์–ต์ œ ์กฐ์ ˆํ•จ์„ ๋ฐœ๊ฒฌํ•˜์˜€๋‹ค. ๊ตฌ์ฒด์ ์œผ๋กœ p21 ํ”„๋กœ๋ชจํ„ฐ์—์„œ FBI-1์€ Sp1์— ์˜ํ•œ ์ „์‚ฌ ํ™œ์„ฑํ™”์— ์ค‘์š”ํ•˜๋‹ค๊ณ  ๋ณด๊ณ ๋œ Sp1-3 GC-box (FBI-1 ๊ฒฐํ•ฉ ๋ถ€์œ„์™€ ์ค‘์ฒฉ๋จ) ์—์„œ ์ „์‚ฌ ํ™œ์„ฑ์ž์ธ Sp1๊ณผ ๋ถ„์ž์ ์ธ ์ž๋ฆฌ ๊ฒฝ์Ÿ์— ์˜ํ•ด ์ „์‚ฌ๋ฅผ ์–ต์ œํ•˜๋ฉฐ, ์ด๋ฅผ ํ†ตํ•ด์„œ Sp1๊ณผ p53๊ฐ„์˜ ์ƒํ˜ธ์ž‘์šฉ์— ์˜ํ•œ ์ „์‚ฌ ํ™œ์„ฑํ™”๋„ ์–ต์ œํ•œ๋‹ค. ๋˜ํ•œ FBI-1์ด p21 ์œ ์ „์ž์˜ ์ „์‚ฌ ์–ต์ œ๋ฅผ ์œ„ํ•ด distal p53 ๊ฒฐํ•ฉ ๋ถ€์œ„์— ๊ฒฐํ•ฉํ•˜์—ฌ ์ „์‚ฌ ํ™œ์„ฑํ™”์‹œํ‚ค๋Š” p53๊ณผ ๊ฒฝ์Ÿ์ ์œผ๋กœ ๊ฒฐํ•ฉํ•˜๋Š” ๊ฒƒ์„ ๋˜ํ•œ ๋ฐœ๊ฒฌํ•˜์˜€๋‹ค. FBI-1์€ ์ผ๋‹จ proximal, distal ์กฐ์ ˆ ๋ถ€์œ„์— ๊ฒฐํ•ฉํ•˜๋ฉด, ์ „์‚ฌ ์–ต์ œ์—์„œ ์ค‘์š”ํ•œ HDAC์ด ํฌํ•จ๋œ mSIN3A, N-CoR, SMRT๊ณผ ๊ฐ™์€ ๋ณด์กฐ์ „์‚ฌ ์–ต์ œ์ธ์ž๋“ค๊ณผ ์ƒํ˜ธ์ž‘์šฉํ•˜์—ฌ, p21 ์œ ์ „์ž์˜ proximal ํ”„๋กœ๋ชจํ„ฐ ๋ถ€์œ„์—์„œ acetylation๋œ histon H3๊ณผ histon H4๋ฅผ deacetylationํ•จ์œผ๋กœ nucleosome์˜ ๊ตฌ์กฐ๋ฅผ ์ด˜์ด˜ํ•˜๊ฒŒ ํ•˜์—ฌ ์ „์‚ฌ๋ฅผ ์–ต์ œ๋ฅผ ํ•œ๋‹ค.๋‚˜์•„๊ฐ€ ์šฐ๋ฆฌ๋Š” p53 ๊ฒฝ๋กœ, ํŠนํžˆ p21์˜ ์ „์‚ฌ ์–ต์ œ๊ฐ€ ์˜๋ฏธํ•˜๋Š” ์ƒ๋ฌผํ•™์ ๊ธฐ๋Šฅ์„ ์—ฐ๊ตฌํ•˜๊ณ ์ž ์„ธํฌ์ฃผ๊ธฐ์˜ FACS ๋ถ„์„, Foci-formation ๋ถ„์„, BrdU-incorporation ์†๋„ ๋“ฑ์„ ์กฐ์‚ฌํ•œ ๊ฒฐ๊ณผ, FACS ๋ถ„์„๊ฒฐ๊ณผ, DNA ํ•ฉ์„ฑ๊ธฐ (S-์ƒ) ์„ธํฌ์˜ ์ˆ˜๊ฐ€ ํ˜„์ €ํžˆ ์ฆ๊ฐ€ํ•จ์„ ๋ณด์˜€๊ณ , ์ด๋Š” BrdU incorporation ์†๋„์™€ ์ผ์น˜ํ•˜์—ฌ FBI-1์€ ์ฆ์‹์ด ๋น ๋ฅธ ์„ธํฌ๋กœ์˜ ํ˜•์งˆ ์ „ํ™˜์„ ์œ ๋„ํ•˜๊ณ  ์„ธํฌ ์ฃผ๊ธฐ๋Š” ์ด‰์ง„์‹œํ‚ด์„ ๋ฐœ๊ฒฌํ•˜์˜€๋‹ค. ์—ฌ๋Ÿฌ ๋ณ‘๋ฆฌ ์•” ์กฐ์ง์˜ ๋ฉด์—ญ ํ™”ํ•™ ์—ผ์ƒ‰์—์„œ๋Š” FBI-1์ด adenocarcinoma์™€ squamous cell carconoma์—์„œ ๋‘๋“œ๋Ÿฌ์ง€๊ฒŒ ๋ฐœํ˜„๋˜๋Š” ๊ฒƒ์„ ๊ด€์ฐฐ๋˜์—ˆ๋‹ค.๊ฒฐ๋ก ์ ์œผ๋กœ FBI-1์€ Arf-Mdm2-p53-p21 (p53 ๊ฒฝ๋กœ) ๊ฒฝ๋กœ์˜ ์ค‘์š”ํ•œ ์–ต์ œ์กฐ์ ˆ ์ „์‚ฌ ์ธ์ž์ด๋ฉฐ ์ด๋ฅผ ํ†ตํ•ด ์„ธํฌ๋ฅผ ์•”์„ธํฌ๋กœ ํ˜•์งˆ์ „ํ™˜ ์‹œํ‚ค๋ฉฐ ์„ธํฌ์˜ ์ฆ์‹์„ ์ด‰์ง„ํ•จ์„ ๋ฐœ๊ฒฌํ•˜์˜€๋‹ค. ์šฐ๋ฆฌ์˜ ์—ฐ๊ตฌ๋Š” ์–ด๋–ป๊ฒŒ ์ƒˆ๋กœ์šด ์ „ ๋ฐœ์•” ์œ ์ „์ž์ธ FBI-1์ด ์•”์„ธํฌ๋กœ์˜ ์ „ํ™˜์„ ์œ ๋ฐœํ•˜๊ณ , ์ข…์–‘์„ธํฌ์˜ ์ฆ์‹์„ ์œ ๋„ํ•˜๋Š”์ง€๋ฅผ ์„ค๋ช…ํ•ด์ฃผ๊ณ  ์žˆ๋‹ค. [์˜๋ฌธ]FBI-1 (Pokemon/ZBTB7a) is a ubiquitous POK family oncogenic transcription factor. Virtually every gene in the Arf-Mdm2-p53-p21 regulatory pathway, important in the regulation of cell cycle progression, was found to be a repression target of FBI-1. In this study, the cell cycle regulator gene p21Waf/Cip1, which is downstream of Arf and p53, was selected for investigation into the molecular mechanism of transcriptional repression. This repression is known to involve FBI-1, p53, Sp1, the FRE (FBI-1 binding site)/Sp1-3 GC-box, and a distal p53-binding element. The FRE and Sp1-3 GC box sequences were found to overlap, and FBI-1 was found to represses transcription by molecular competition with Sp1 for binding to the Sp1-3 GC-box, an element critical in transcriptional regulation by Sp1 and synergistic transcriptional activation by Sp1 and p53. FBI-1 was also found to compete with p53 for binding to the distal p53-binding element to repress transcription. FBI-1 bound to sequences from both the proximal and distal regulatory elements. FBI-1 also interacted with corepressors such as mSin3A, N-CoR, and SMRT, and such interactions led to deacetylation of the Ac-H3 and Ac-H4 histones at the proximal promoter, which is likely an important step in transcriptional repression.FBI-1 expression caused cellular transformation and promoted cell cycle proliferation, as seen by a significant increase in the number of cells in the S-phase. Immunohistochemical staining showed that FBI-1 is prominently detected in adenocarcinoma (particularly in colon cancer) and squamous cell carcinoma cells, which express only low levels of p21. Overall, data from this study suggests that FBI-1 is the major regulator of the Arf-Mdm2-p53-p21Waf/Cip1 pathway and that FBI-1 promotes oncogenic transformation and tumor cell growth.ope
    corecore